NCT00725621 - Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED) | Biotech Hunter

Enrollment

516

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

Infliximab

Remicade induction therapy consisting of three Remicade infusions in weeks 0, 2, and 6 given in specialized centers. Maintenance therapy will consist of another maximal 6 infusions given in doses and intervals due to discretion of physicians.